Novartis accelerates cancer immunotherapy efforts with Aduro Biotech alliance and launch of new immuno-oncology research group

Novartis accelerates cancer immunotherapy efforts with Aduro Biotech alliance and launch of new immuno-oncology research group Novartis announced today that it is stepping up its efforts to harness the body’s immune system to combat cancer. The company has entered into a major multiyear alliance with Aduro Biotech that is focused on the discovery and development of next generation cancer immunotherapies ... Read More »

Grey Goose and Gander

Grey Goose and Gander  Once upon a time, there was a peaceful kingdom. The king heard rumors that barbarians were going to attack his castle soon. So he called his twofavorite pets – the huge grey goose and gander. “My dear goose and gander, our kingdom is in danger. Take my daughter to a safe place on top of the ... Read More »

VIVAN’s CSR

VIVAN’s CSR VIVAN is firm in its commitment to social responsibility and considers Human and Social Development as an integral part of our working process, aiming to make a difference in people’s lives. We deliver it with unstilted support from each individual in the Organization, which is a motivational factor at higher end of Human needs for each individual, that ... Read More »

US FDA approves Semler Scientific’s next generation PAD testing system

US FDA approves Semler Scientific’s next generation PAD testing system The US Food and Drug Administration (FDA) has granted 510(k) marketing clearance for Semler Scientific’s next generation peripheral artery disease (PAD) testing system. The next generation system features convenience and ease of use characteristics along with compatibility to electronic medical record systems for easy accessibility of data. The system was ... Read More »

THE BRICK

THE BRICK A young and successful executive was traveling down a neighborhood street, going a bit too fast in his new Jaguar. He was watching for kids darting out from between parked cars and slowed down when he thought he saw something. As his car passed, no children appeared. Instead, a brick smashed into the Jag’s side door! He slammed ... Read More »

GSK becomes partner in new global fund to accelerate dementia research

GSK becomes partner in new global fund to accelerate dementia research GSK today announced it will be a key partner, with an investment of $25m (approx £17m), in a pioneering new global fund for dementia research. The Dementia Discovery Fund, which is being established by the UK government with initial commitments totalling $100m, brings together leading pharmaceutical companies, the UK ... Read More »

Drug major LupinBSE -0.77 % has inked a pact to acquire an additional 40 per cent stake in South Africa’s Pharma Dynamics

Drug major LupinBSE -0.77 % has inked a pact to acquire an additional 40 per cent stake in South Africa’s Pharma Dynamics NEW DELHI: Drug major LupinBSE -0.77 % has inked a pact to acquire an additional 40 per cent stake in South Africa’s Pharma Dynamics, taking its holding in the company to 100 per cent. Lupin had earlier acquired ... Read More »

Ranbaxy merger: Sun Pharma readies new leadership team

Sun Pharma readies new leadership team Taking forward its acquisition of Ranbaxy Laboratories  , Sun Pharma  has put in place a team of top executives, including Dilip Shanghvi’s son Aalok Shanghvi, to lead the businesses of both the organisations. While the leadership team is comprised mainly from the representatives of Sun Pharma, it also has executives from Ranbaxy, drawing upon ... Read More »

Leadership Lessons From Virgin Hotels, Courtesy Of Richard Branson And CEO Raul Leal

Leadership Lessons From Virgin Hotels, Courtesy Of Richard Branson And CEO Raul Leal “Here’s a great story about how Richard (Branson) works with his companies, in this case ours,” Raul Leal, CEO of Virgin Hotels, tells me. “We picked this building (the former Old Dearborn Bank Building in downtown Chicago) to build out as the future flagship of Virgin Hotels ... Read More »

Suven Life Sciences gets patents for neuro-degenerative drug

Suven Life Sciences gets patents for neuro-degenerative drug  Pharmaceutical firm Suven Life SciencesBSE 0.45 % has been granted a patent each by Eurasia and Israel for drug used in the treatment of neuro-degenerative diseases. Neuro-degenerative ailments include Alzheimer’s disease, Schizophrenia and Parkinson’s disease. In a BSE filing, the company said it has received “grant of one product patent from Eurasia ... Read More »

BIGTheme.net • Free Website Templates - Downlaod Full Themes
Social Media Auto Publish Powered By : XYZScripts.com